The effects of Opium Tincture in the control of clinical signs associated with methamphetamine

Phase 2

• Conditions: Methamphetamin dependency.; Psychostimulants with abuse potential

• Registration Number: IRCT2015080223470N1
• Lead Sponsor: Vice Chancellor for Research, University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Dependence on methamphetamine (more than 10 times the regular use of methamphetamine or 10 days); Urine tests positive for methamphetamine; Age 18-65 years; Independence and no use of drugs or other addictive drugs at the time of presentation; Complete the consent form; To track patient;
Exclusion criteria: Unwillingness person to continue treatment; Patient self-medication or participate in another study; Other addictive drugs or alcohol or drug use during the study period; Non-compliance with medication orders during the study; Coming out of treatment (imprisonment, death, ...); Any behavior that resulted in dismissal laws rehab clinic patient; There are other mental disorders that require treatment or the risk of suicide; Significant diseases of the Thyroid, Kidney, Liver, Gastrointestinal or Cardiovascular; History of diabetes or Heart attack, Seizures, Glaucoma, Tick, Tardive dyskinesia; Female without adequate contraception pregnancy or lactation; Tincture of opium abusers; A history of allergy to Haloperidol; Simultaneous treatment with antipsychotics or mood stabilizers or CYP 2D6 inhibitors Contains: Amiodarone, Bupropion, Celecoxib, Cimetidine, Chlorpromazine, Clomipramine, Fluoxetine, Haloperidol, Methadone, Moclobemide, Paroxetine, Quinidine, Ritonavir, Sertraline, Terbinafine and Thioridazine; So dangerous side effects of medications or the patient is intolerable.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sleep condition improve. Timepoint: Befor and during and after invetervention. Method of measurement: Beck questionnaire.;Psychotic reaction. Timepoint: Befor and during and after invetervention. Method of measurement: Beck questionnaire and Psychological exam.;Craving. Timepoint: Befor and during and after invetervention. Method of measurement: Psychological exam.